Jeff Cohen
Stock Analyst at Ladenburg Thalmann
(2.98)
# 1,299
Out of 4,884 analysts
12
Total ratings
72.73%
Success rate
29.16%
Average return
Main Sectors:
Stocks Rated by Jeff Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $1.45 | $0.70 | +106.85% | 1 | May 5, 2025 | |
| CBLL CeriBell | Initiates: Buy | $32 | $18.94 | +68.95% | 1 | Apr 4, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $31 | $13.52 | +129.29% | 1 | Feb 20, 2025 | |
| LGCY Legacy Education | Maintains: Buy | $9.1 → $11 | $10.86 | -0.55% | 2 | Feb 14, 2025 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $3.37 | - | 1 | Nov 15, 2024 | |
| SNOA Sonoma Pharmaceuticals | Initiates: Buy | $65 | $2.97 | +2,088.55% | 1 | Sep 5, 2023 | |
| DKNG DraftKings | Initiates: Overweight | $52 | $40.77 | +27.54% | 1 | Jul 1, 2020 | |
| SE Sea Limited | Initiates: Overweight | $130 | $149.47 | -13.03% | 1 | Jul 1, 2020 | |
| TTWO Take-Two Interactive Software | Maintains: Equal-Weight | $110 → $130 | $240.11 | -45.86% | 3 | May 21, 2020 |
NeuroOne Medical Technologies
May 5, 2025
Initiates: Buy
Price Target: $1.45
Current: $0.70
Upside: +106.85%
CeriBell
Apr 4, 2025
Initiates: Buy
Price Target: $32
Current: $18.94
Upside: +68.95%
Beta Bionics
Feb 20, 2025
Initiates: Buy
Price Target: $31
Current: $13.52
Upside: +129.29%
Legacy Education
Feb 14, 2025
Maintains: Buy
Price Target: $9.1 → $11
Current: $10.86
Upside: -0.55%
Bionano Genomics
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.37
Upside: -
Sonoma Pharmaceuticals
Sep 5, 2023
Initiates: Buy
Price Target: $65
Current: $2.97
Upside: +2,088.55%
DraftKings
Jul 1, 2020
Initiates: Overweight
Price Target: $52
Current: $40.77
Upside: +27.54%
Sea Limited
Jul 1, 2020
Initiates: Overweight
Price Target: $130
Current: $149.47
Upside: -13.03%
Take-Two Interactive Software
May 21, 2020
Maintains: Equal-Weight
Price Target: $110 → $130
Current: $240.11
Upside: -45.86%